PL2590966T3 - Związki chinazolinowe - Google Patents

Związki chinazolinowe

Info

Publication number
PL2590966T3
PL2590966T3 PL11800101T PL11800101T PL2590966T3 PL 2590966 T3 PL2590966 T3 PL 2590966T3 PL 11800101 T PL11800101 T PL 11800101T PL 11800101 T PL11800101 T PL 11800101T PL 2590966 T3 PL2590966 T3 PL 2590966T3
Authority
PL
Poland
Prior art keywords
quinazoline compounds
quinazoline
compounds
Prior art date
Application number
PL11800101T
Other languages
English (en)
Polish (pl)
Inventor
Weihan Zhang
Wei-Guo Su
Haibin Yang
Yumin Cui
Yongxin Ren
Xiaoqiang Yan
Original Assignee
Hutchison Medipharma Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hutchison Medipharma Limited filed Critical Hutchison Medipharma Limited
Publication of PL2590966T3 publication Critical patent/PL2590966T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
PL11800101T 2010-06-30 2011-05-25 Związki chinazolinowe PL2590966T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2010/074792 WO2012000182A1 (en) 2010-06-30 2010-06-30 Quinazoline compounds
EP11800101.5A EP2590966B1 (en) 2010-06-30 2011-05-25 Quinazoline compounds

Publications (1)

Publication Number Publication Date
PL2590966T3 true PL2590966T3 (pl) 2017-05-31

Family

ID=45401313

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11800101T PL2590966T3 (pl) 2010-06-30 2011-05-25 Związki chinazolinowe

Country Status (22)

Country Link
US (1) US9168253B2 (pt-PT)
EP (1) EP2590966B1 (pt-PT)
JP (1) JP5736452B2 (pt-PT)
KR (1) KR101480481B1 (pt-PT)
AU (1) AU2011274183B2 (pt-PT)
BR (1) BR112012033344B1 (pt-PT)
CA (1) CA2801814C (pt-PT)
DK (1) DK2590966T3 (pt-PT)
ES (1) ES2604929T3 (pt-PT)
HK (1) HK1179954A1 (pt-PT)
HR (1) HRP20161490T1 (pt-PT)
HU (1) HUE029801T2 (pt-PT)
LT (1) LT2590966T (pt-PT)
MX (1) MX2012015047A (pt-PT)
MY (1) MY172201A (pt-PT)
PL (1) PL2590966T3 (pt-PT)
PT (1) PT2590966T (pt-PT)
RS (1) RS55470B1 (pt-PT)
RU (1) RU2530887C2 (pt-PT)
SG (1) SG186410A1 (pt-PT)
SI (1) SI2590966T1 (pt-PT)
WO (2) WO2012000182A1 (pt-PT)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR092289A1 (es) 2011-11-14 2015-04-15 Sunshine Lake Pharma Co Ltd Derivados de aminoquinazolina y sus sales y metodos de uso
WO2018099451A1 (zh) * 2016-12-01 2018-06-07 和记黄埔医药(上海)有限公司 化合物的晶型
KR101957464B1 (ko) 2018-10-18 2019-03-12 대흥전력기술 주식회사 활선 상태에서 지상기기의 점검 및 누유 보수방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4444762A (en) 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
GB9718972D0 (en) * 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
CN101619043B (zh) * 2008-06-30 2013-06-05 和记黄埔医药(上海)有限公司 喹唑啉衍生物及其医药用途
US8426430B2 (en) * 2008-06-30 2013-04-23 Hutchison Medipharma Enterprises Limited Quinazoline derivatives

Also Published As

Publication number Publication date
US9168253B2 (en) 2015-10-27
MX2012015047A (es) 2013-02-07
KR101480481B1 (ko) 2015-01-09
RU2530887C2 (ru) 2014-10-20
SI2590966T1 (sl) 2016-12-30
WO2012000182A1 (en) 2012-01-05
AU2011274183B2 (en) 2013-09-26
ES2604929T3 (es) 2017-03-10
EP2590966A4 (en) 2014-01-15
RU2012153174A (ru) 2014-08-10
EP2590966B1 (en) 2016-08-31
CA2801814C (en) 2015-04-07
WO2012000356A1 (en) 2012-01-05
MY172201A (en) 2019-11-15
EP2590966A1 (en) 2013-05-15
DK2590966T3 (en) 2016-12-19
HRP20161490T1 (hr) 2016-12-16
HK1179954A1 (en) 2013-10-11
RS55470B1 (sr) 2017-04-28
BR112012033344A2 (pt) 2016-11-29
HUE029801T2 (en) 2017-04-28
US20130172373A1 (en) 2013-07-04
PT2590966T (pt) 2016-11-29
LT2590966T (lt) 2016-11-25
SG186410A1 (en) 2013-01-30
BR112012033344B1 (pt) 2020-12-15
KR20130031358A (ko) 2013-03-28
AU2011274183A1 (en) 2013-01-10
JP5736452B2 (ja) 2015-06-17
CA2801814A1 (en) 2012-01-05
JP2013529653A (ja) 2013-07-22

Similar Documents

Publication Publication Date Title
IL223783A0 (en) Pro-neurogenic compounds
GB201008134D0 (en) Compounds
GB201015949D0 (en) Compounds
HK1187908A1 (zh) 咪唑並三嗪酮化合物
GB201020179D0 (en) New compounds
GB201007286D0 (en) New compounds
AP2012006641A0 (en) New compounds
EP2648516A4 (en) SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS
GB201007347D0 (en) Compounds
EP2605658A4 (en) SPIROXAZOLIDINONVERBINDUNGEN
EP2649050A4 (en) LINKS
GB201002563D0 (en) Compounds
IL219504A0 (en) Quinazoline compounds
GB201008209D0 (en) Compounds
GB201001688D0 (en) Compounds
HK1179954A1 (en) Quinazoline compounds
GB201002216D0 (en) Compounds
GB201015537D0 (en) Compounds
GB201008210D0 (en) Compounds
GB201001796D0 (en) Compounds
GB201021494D0 (en) Compounds
GB201022042D0 (en) Compounds
GB201019227D0 (en) Compounds
GB201015757D0 (en) Compounds
GB201015145D0 (en) Compounds